The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells

Anticancer Research

Volumn 31, Issue 5, 2011, Pages 1653-1658

  Inaba, Nobuharu ^a,b   Kimura, Masaki ^a   Fujioka, Kouki ^b   Ikeda, Keiichi ^b   Somura, Hiroko ^b   Akiyoshi, Kouhei ^b   Inoue, Yuriko ^c   Nomura, Mayumi ^b   Saito, Yuji ^b   Saito, Hidetsugu ^a   Manome, Yoshinobu ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

Cell cycle; Glioma; Ionizing radiation; PTEN; Radiosensitivity; Temozolomide

Indexed keywords

ADENOVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TEMOZOLOMIDE;

ARTICLE; CANCER GENE THERAPY; CELL CYCLE; CELL PROLIFERATION; DRUG SENSITIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; MALIGNANT GLIOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RECEPTOR UPREGULATION;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DACARBAZINE; GENE THERAPY; GLIOMA; HUMANS; PTEN PHOSPHOHYDROLASE; RADIATION TOLERANCE; RADIATION, IONIZING; TUMOR CELLS, CULTURED;

EID: 79958138485     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. DeAngelis LM: Brain tumors. N Engl J Med 344: 114-123, 2001.
2. Kang CS, Zhang ZY, Jia ZF, Wang GX, Qiu MZ, Zhou HX, Yu SZ, Chang J, Jiang H and Pu PY: Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 13: 530-538, 2006.
3. Dong L, Pu PY, Wang H, Wang GX, Kang CS and Jiao DR: Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway. Zhonghua Bing Li Xue Za Zhi 35: 232-236, 2006 (in Chinese). (Pubitemid 43805961)
4. 2M. Oncogene 24: 829-837, 2005.
5. Kanu OO, Hughes B, Di C, Lin N, Fu J, Bigner D D, Yan H and Adamson C: Glioblastoma multiforme oncogenomics and signaling pathways. Clin Med Oncol 3: 39-52, 2009.
6. Stewart AL, Mhashilkar AM, Yang XH, Ekmekcioglu S, Saito Y, Sieger K, Schrock R, Onishi E, Swanson X, Mumm JB, Zumstein L, Watson GJ, Snary D, Roth JA, Grimm E A, Ramesh R and Chada S: PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells. Mol Med 8: 451-461, 2002. (Pubitemid 36337489)
7. Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk A R, Nicholas M K, Stokoe D and Haas-Kogan D A: Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 8: 1100-1106, 2002.
8. Knobbe CB, Merlo A and Reifenberger G: PTEN signaling in gliomas. Neuro Oncol 4: 196-211, 2002.
9. Koul D: PTEN signaling pathways in glioblastoma. Cancer Biol Ther 7: 1321-1325, 2008.
10. Vazquez F, Ramaswamy S, Nakamura N and Sellers W R: Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20: 5010-5018, 2000. (Pubitemid 30431555)
11. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK and Steck PA: Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59: 1820-1824, 1999.
12. Endersby R and Baker SJ: PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27: 5416-5430, 2008.
13. Manome Y, Kobayashi T, Mori M, Suzuki R, Funamizu N, Akiyama N, Inoue S, Tabata Y and Watanabe M: Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet. Anticancer Res 26: 3317-3326, 2006. (Pubitemid 44701503)
14. Takeshita I, Takaki T, Kuramitsu M, Nagasaka S, Machi T, Ogawa H, Egami H, Mannoji H, Fukui M and Kitamura K: Characteristics of an established human glioma cell line, KNS-42. Neurol Med Chir (Tokyo) 27: 581-587, 1987.
15. Barth R F and Kaur B: Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 94: 299-312, 2009.
16. Barker M, Hoshino T, Gurcay O, Wilson C B, Nielsen S L, Downie R and Eliason J: Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 33: 976-986, 1973.
17. Parr M J, Manome Y, Tanaka T, Wen P, Kufe D W, Kaelin W G, Jr. and Fine H A: Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat Med 3: 1145-1149, 1997.
18. Reyderman L, Statkevich P, Thonoor CM, Patrick J, Batra VK and Wirth M: Disposition and pharmacokinetics of temozolomide in rat. Xenobiotica 34: 487-500, 2004.
19. Saito Y, Gopalan B, Mhashilkar AM, Roth JA, Chada S, Zumstein L and Ramesh R: Adenovirus-mediated PTEN treatment combined with caffeine produces a synergistic therapeutic effect in colorectal cancer cells. Cancer Gene Ther 10: 803-813, 2003. (Pubitemid 37414111)
20. Manome Y, Wen PY, Hershowitz A, Tanaka T, Rollins BJ, Kufe DW and Fine HA: Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol Immunother 41: 227-235, 1995.
21. Han L, Zhang AL, Xu P, Yue X, Yang Y, Wang GX, Jia ZF, Pu PY and Kang CS: Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo. Med Oncol 27: 843-852.
22. Inaba N, Ishizawa S, Kimura M, Fujioka K, Watanabe M, Shibasaki T and Manome Y: Effect of inhibition of me ROCK isoform on RT2 malignant glioma cells. Anticancer Res 30: 3509-3514.
23. Manome Y, Watanabe M, Abe T, Tomita M, Watanabe S, Yokokawa Y, Takahashi Y, Ishii K, Kimura A, Murakami M, Nagata M, Shibata T, Nakamura M, Tanigawa N and Ohno T: Transduction of thymidine Phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Anticancer Res 21: 2265-2272, 2001. (Pubitemid 33054385)
24. Manome Y, Wen PY, Dong Y, Tanaka T, Mitchell BS, Kufe DW and Fine HA: Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med 2: 567-573, 1996. (Pubitemid 26150684)
25. 6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea. Anticancer Res 22: 2029-2036, 2002. (Pubitemid 34857019)
26. Cheng RB, Ma RJ, Wang ZK, Yang SJ, Lin XZ, Rong H and Ma Y: PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells. Mol Cell Biochem.
27. Levitt RJ, Georgescu MM and Pollak M: PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. Biochem Biophys Res Commun 336: 1056-1061, 2005. (Pubitemid 41383429)
28. Manome Y, Watanabe M, Futaki K, Ishiguro H, Iwagami S, Noda K, Dobashi H, Ochiai Y, Ohara Y, Sanuki K, Kunieda T and Ohno T: Development of a syngenic brain-tumor model resistant to chloroethyl-nitrosourea using a methylguanine DNA methyltransferase cDNA. Anticancer Res 19: 5313-5318, 1999. (Pubitemid 30103367)
29. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005. (Pubitemid 40349501)
30. Ohneseit PA, Prager D, Kehlbach R and Rodemann HP: Cell cycle effects of topotecan alone and in combination with irradiation. Radiother Oncol 75: 237-245, 2005. (Pubitemid 40805256)